Introduction
It is more than two years since it was ®rst reported 1 that most obese people have elevated serum leptin concentrations and numerous subsequent reports have con®rmed these original ®ndings, sometimes describing concentrations far higher in the obese than the lean. Given the obvious failure of these high concentrations of leptin to produce changes in energy intake or expenditure that restore fat mass to normal, it was reasonable to propose that`leptin resistance' is a primary cause of obesity, analogous to insulin resistance in Type 2 diabetes. Alternatively, leptin resistance might, like insulin resistance, be a secondary consequence of obesity. There is, however, scant direct evidence for leptin resistance in humans, whereas there is rather better evidence that inadequate leptin secretion is a factor pre-disposing some individuals to obesity. Aside from a few rare examples, where massive obesity is associated with a single mutation in the OB gene 2 or the OB receptor gene, 3 there are at least four linkage studies which suggest that the OB or an adjacent gene might be involved in human obesity. 4, 5 There are also studies which link lower leptin concentrations than would be expected from the body mass index (BMI) to a pre-disposition to weight gain. 6 ± 8 Evidence for leptin resistance, on the other hand, has been based solely on the ®nding that obese humans generally have elevated serum or plasma leptin concentrations compared to lean subjects. We suggest that this is not evidence for leptin resistance, unless one extends the meaning of the term such that it becomes of little value.
Raised leptin levels in obesity
Clearly the concentration of any molecule that is involved in the regulation of body adiposity will alter in a direction opposing the deposition of excess fat, unless it is part of a defective regulatory pathway that is responsible for the excessive fat deposition in the ®rst place. We suggest that leptin concentrations are not raised in the majority of obese individuals because of leptin resistance, but because leptin is opposing other forces that promote obesity.
It has been argued that obese subjects who have high leptin concentrations must be leptin resistant or they would not be obese. However, all that the high leptin concentrations may show us is what we already know: that body fat content is not tightly regulated in most people, mechanisms that prevent weight gain being weak. In this sense, all humans may be resistant to leptin: obese subjects are not necessarily any more resistant to the hormone than lean subjects. If we could measure the concentration of other messenger molecules involved in weight regulation as easily as we can measure leptin, we might ®nd that they also change in obesity in a direction that opposes further weight gain. So obese subjects might equally be described as resistant' to these other molecules. By way of a speci®c example, it is interesting that in four studies of Caucasian subjects sympathetic activity was correlated with body fat content. 9 Perhaps, therefore, many obese individuals are also`resistant' to the regulation of obesity by the sympathetic nervous system in the same sense that they are`resistant' to leptin.`Resistance' in this context does not, however, mean that the leptin or noradrenaline is having no effect, or even less effect than in lean individuals. One only has to consider the gross obesity of individuals who lack functional leptin, 2 to appreciate that leptin must play some role in resisting weight gain in most obese subjects.
If leptin resistance is a cause rather than a consequence of obesity, leptin concentrations would be expected to be raised in subjects who are prone to obesity but have slimmed. No studies have been described on subjects who have slimmed to a BMI in the normal range, but what evidence there is does not support this proposition. In one study a mean weight loss of 21% achieved over 74 ± 110 d was associated with a fall in leptin concentrations of 76%. 10 In another study over 10 months in 52 obese women, a mean fall in BMI of 2.7 kgam 2 was associated with a reduction in plasma leptin from 30 to 22 ngaml serum, much as would be predicted. Moreover there was no evidence that subjects with the highest baseline leptin concentrations ± those that might be called most`leptin resistant' ± had the greatest dif®culty in losing weight. 11 If the association of elevated leptin concentrations with obesity is an argument for leptin resistance, what are we to infer from the low leptin concentrations found in anorexia nervosa? The authors of one report 12 do not exclude the possibility that patients with anorexia nervosa have an increased sensitivity to leptin. It seems more likely to us, however, that leptin concentrations fall in a largely unsuccessful attempt to prevent a disease whose origins are primarily cultural and cognitive. Indeed, one can actually argue that anorexic patients have an underlying problem of leptin resistance. Thus when weight gain was achieved by behavioural therapy, their plasma leptin concentrations increased to levels well in excess of those of controls matched for BMI. 13 A more reasonable explanation of this ®nding is, however, that these patients had adapted to a low body fat content, which they defended when in positive energy balance with hypersecretion of leptin. Conversely, obese subjects may adapt to their high body fat content and respond to fasting with a rapid fall in leptin secretion. 14 The rapid decreases in plasma leptin following short-term fasting or food restriction can be seen when there is little or no detectable change in body fat, indicating that leptin secretion is not only determined by the size of the fat reserves. 10, 14 This has been clearly demonstrated in animal studies in which a range of factors which acutely affect leptin production are recognised. 15 Such regulatory in¯uences could also be responsible for the disproportionate response of leptin to increases in fat stores. 16 Raised leptin concentrations can also be observed in normal lean subjects. A recent study 17 found that subjects habitually consuming a high-fat diet have raised leptin concentrations and a higher basal metabolic rate (BMR) than subjects with the same BMI and adiposity habitually consuming a low-fat diet, suggesting that overnutrition, like undernutrition, can in¯uence leptin secretion independently of its effects on adiposity.
Analogy with diabetes?
The presumption that obesity must be a consequence of a de®cit in leptin secretion or leptin action stems in part from an inappropriate analogy with diabetes: Type 1 diabetes is due to a failure of insulin secretion, whereas Type 2 diabetes results from insulin resistance coupled with inadequate insulin secretion to cope with the insulin resistance. In the early stages of Type 2 diabetes, elevated fasting blood glucose is associated with elevated insulin concentrations and this has been shown to be a consequence of insulin resistance. Therefore, the argument goes, elevated body fat associated with elevated leptin concentrations must indicate leptin resistance.
Why, however, should one restrict the analogy between diabetes and obesity to the fasting state? After a meal, both blood glucose and insulin are raised, not because of insulin resistance, but because insulin is responding to an in¯ux of glucose. Similarly, leptin may be raised in obesity, not because of leptin resistance, but because fat stores are high. It is the stimulus to hormone secretion that is high. Of course fat stores in humans build up over a period of months or years, whereas blood glucose concentrations rise rapidly after a single meal. Similarly, insulin acts rapidly to control blood glucose concentrations, whereas leptin does not have a signi®cant impact on body fat content within a day. The different timescales of the insulinaglucose and leptinafat systems make it dif®cult to draw simple analogies.
Timescale is not the only difference between how blood glucose and body fat are regulated. Insulin is overwhelmingly the dominant regulator of blood glucose concentration. There is no`Type 3' diabetes with the absence of involvement of either defective insulin secretion or action. Moreover, insulin acts directly on the major glucose utilising tissues and other factors that effect insulin action ultimately modulate the action of insulin on these same tissues. In contrast, energy balance may well be regulated by molecules that are not involved in the leptin pathway (gut peptides, for example), or (like peripheral noradrenaline) are suf®ciently removed from the site of leptin action that to describe a defect in their production or action as leptin resistance is to divert attention from the real problem. More important, however, than leptin or any other physiological mechanism that might predispose humans to obesity is the in¯uence of culture or environment. Obesity resembles anorexia nervosa in being primarily due to cultural factors, with only about 25 ± 40% of the variance in BMI being determined by our genes. 4 To explain the rapid increase in the incidence of obesity over the last 40 years as an increase in leptin resistance would be merely to argue that leptin is relatively impotent in controlling our liking for palatable, high fat, readily available food or, bearing in mind that we are actually eating less than we used to, 18 leptin does not increase our desire to exercise.
If we consider how insulin resistance is determined, we can envisage equivalent ways by which leptin resistance might be demonstrated. By analogy with the hyperinsulinaemic euglycaemic clamp, leptin Leptin resistance JRS Arch et al could be infused to the same level in obese and lean subjects and hunger, food intake or metabolic rate measured. Alternatively, tissues from obese individuals might be shown to be less responsive to leptin than those from lean individuals. Recent papers describe lipolytic responses to leptin in rodent adipose tissue and adipocytes 19, 20 and so it is possible that lipolytic responses can be compared in adipocytes from obese and lean humans. Should a difference be found, it will be important to compare adipocytes from post-obese and lean humans to determine whether leptin resistance is a primary cause of obesity or a secondary consequence.
Insights from rodents
Leptin resistance clearly does occur in some laboratory rodents. In faafa rats and dbadb mice, it is the primary cause of obesity, since these mutants have defective leptin receptors. Other animal models of obesity may, however, offer greater insights into why obesity in man tends to be associated with raised plasma leptin concentrations.
Lethal yellow (Ayaa) mice, in which the Agouti peptide is ectopically expressed, are resistant to both central and peripheral administration of leptin. Nevertheless, the leptin signal appears to be sensed in these mice, since their hypothalami contain low concentrations of the mRNA for Agouti-related peptide, a gene that is overexpressed in obaob mice. 21 Lethal yellow obese mice also express normal levels of neuropeptide Y (NPY) mRNA in the arcuate nucleus, whereas obaob and dbadb mice contain high concentrations. 22 It seems likely that the concentration of leptin is so high in lethal yellow obese mice that exogenous leptin can have no further effect. Interestingly, if these mice are also made leptin de®cient by introducing the ob gene, they become even more obese, but are then sensitive to leptin. 23 This is easily explained as the leptin system is now operating from a zero baseline.
Diet-induced obesity using high-fat or`cafeteria' diets is perhaps the best available model for most human obesity, particularly as it demonstrates that the hedonic qualities of the diet are quite capable of overriding the effects of any physiological satiety signal, and result in hyperphagia in rats and humans alike. 24 Leptin is relatively ineffective in reducing food intake and body weight in rodents fed on a high fat diet, 25, 26, 27 but when rats that have been fed on such a diet are returned to standard laboratory diet, their food intake immediately falls below that of rats fed on laboratory diet throughout. 26 This suggests that sensitivity to leptin was unaltered on the high-fat diet, but leptin failed to repress or restrain intake due to its inability to compete with the highly-palatable, energydense diet. As soon as the animals were restored to the monotonous chow diet, intake responded immediately to the elevated leptin levels.
Central administration of leptin is more effective than peripheral administration in diet-induced obese mice. 28, 29 A possible explanation for this is that centrally administered leptin produces a suf®ciently strong stimulus to make an impact upon diet-induced hyperphagia. However, this ®nding has raised the possibility that there is a defect in the transport of leptin into the brain. A similar proposal has been put forward to explain`leptin resistance' in humans, on the basis that the relationship between plasma and CSF leptin concentrations is not linear. 30, 31 This probably re¯ects the fact that the transport of leptin into the brain is by a saturable mechanism. 32 It is possible that in obesity the transporter is close to saturation with leptin and so the plasma leptin concentration is near the top of the concentrationresponse curve. Further administration of peripheral leptin would have little effect. However, since leptin would be exerting a near-maximal effect, it would seem inappropriate to describe this situation as one of leptin resistance. Of course, it is possible that the transport system is down-regulated in obesity, but this has not been demonstrated. In fact Considine and Caro 33 have recently commented that saturation of the transport of leptin into the CSF is probably not the initiating cause of obesity in humans, since saturation only occurs at blood levels that are associated with extreme obesity.
The brown fat de®cient (UCP-DTA) mouse, in which expression of diphtheria toxin is driven by the uncoupling protein-1 promoter, provides a particularly intriguing example of leptin resistance in the rodent. It is not surprising that leptin fails to stimulate thermogenesis in these mice since they lack brown fat, but why does leptin also fail to reduce food intake? Moreover, resistance is present even before hyperleptinaemia develops. Therefore resistance is not secondary to hyperleptinaemia or simply due to leptin levels being beyond the concentration-response range. 34 However, as in the lethal yellow mouse and the diet-induced obese rat, hypothalamic NPY mRNA concentrations are reduced after hyperleptinaemia develops, suggesting that the leptin signal is sensed. 35 A clue to the leptin resistance of the brown fat de®cient mouse lies in the link between its hyperphagia and defective brown fat thermogenesis. When housed at an environmental temperature below thermoneutrality (29a33 C for ratsamice), animals increase their food intake to help maintain body temperature via non-shivering (including dietinduced) thermogenesis. Thus, with a reduced capacity for brown fat thermogenesis, it is not surprising that the UCP-DTA mouse is hyperphagic, and its apparent leptin resistance is simply due to the fact that maintenance of homeothermy is more important for survival than resisting obesity.
It has been proposed that leptin resistance is induced by overactivity of the hypothalamic-pituitary-adrenal axis and raised glucocorticoid concentrations. 36 Thus adrenalectomy enhances the effects of Leptin resistance JRS Arch et al leptin on food intake and body weight in rats, and dexamethasone restores the sensitivity to normal. 37 Although this is an appealing theory, it must be remembered that adrenalectomy also ameliorates or arrests obesity in dbadb mice 38 and faafa rats, 39 both of which are resistant to leptin due to mutations in the leptin receptor gene. The impressive effects of adrenalectomy and their reversal by glucocorticoid replacement, together with studies manipulating central corticotropin (CRH) levels, 40 strongly implicate CRH as a mediator of leptin's effects that acts downstream from the leptin receptor.
Finally, it should be noted that animals that lack leptin (for example, obaob mice) or have obvious leptin resistance (for example, dbadb mice, faafa rats) fail to achieve puberty and are infertile. However, there is no evidence for sterility or failure to reach puberty in any of the so-called`leptin resistant' diet obese rodent models, and neither is there in the majority of obese humans.
Conclusion
Does leptin resistance occur in man? Of course, to some degree it must. As in other biological systems there is likely to be a genetically-based variability between individuals in their sensitivity to leptin. Moreover, as the leptin concentration rises within an individual, there is likely to be some down-regulation of leptin receptors or those mechanisms that couple the receptor to their response. More simplistically, as the leptin concentration rises it will reach a¯atter part of the concentration-response curve. What this article challenges is the facile description of human obesity as being due to`leptin resistance,' simply because it is associated with raised plasma leptin concentrations. Obesity has a number of causes, cultural in¯uences being of particular importance, and to combine them all into the term`leptin resistance' is misleading. Is leptin resistance' a primary cause of obesity, a secondary phenomenon that exacerbates the main cause, or in practice a term that indicates that body weight is not well-regulated by leptin or anything else?
Despite our concerns with the widespread and indiscriminate use of the term`leptin resistance', it does raise one important issue: is exogenous leptin likely to be very effective as an anti-obesity agent in those subjects in whom blood levels are already raised? If leptin receptors are already strongly stimulated, giving more may be of little bene®t. The same question can also be asked of targets downstream of leptin. For example, if NPY levels are already low, how effective will NPY receptor antagonists be? Of course, there may still be ample potential for such agents to achieve a therapeutic bene®t, but perhaps leptin or NPY receptor antagonists will be of most bene®t in those who are attempting to restrain their energy intake and increase the amount of exercise that they take. In these subjects, there is a reduction in leptin levels 10, 11, 41, 42 which will oppose their efforts, but they will also become more sensitive to exogenous leptin, and indeed to other anti-obesity agents that act via physiological mechanisms. Drugs which are most effective in those who help themselves would obviously be more acceptable ethically and less liable to abuse than those which might endorse a life of gluttony and sloth.
